viatrisatorvastigen 40 mg compr. pellic.
viatris gx bv-srl - atorvastatine calcique trihydraté 43,376 mg - eq. atorvastatine 40 mg - comprimé pelliculé - atorvastatin
viatrisatorvastigen 40 mg compr. pellic.
viatris gx bv-srl - atorvastatine calcique trihydraté 43,376 mg - eq. atorvastatine 40 mg - comprimé pelliculé - atorvastatin
viatrisatorvastigen 80 mg compr. pellic.
viatris gx bv-srl - atorvastatine calcique trihydraté 86,751 mg - eq. atorvastatine 80 mg - comprimé pelliculé - atorvastatin
viatrisatorvastigen 80 mg compr. pellic.
viatris gx bv-srl - atorvastatine calcique trihydraté 86,751 mg - eq. atorvastatine 80 mg - comprimé pelliculé - atorvastatin
leflunomide viatris 10 mg, comprimé pelliculé
viatris sante - léflunomide 10 mg - comprimé - 10 mg - pour un comprimé > léflunomide 10 mg - pharmaco-thérapeutique immunosuppresseurs sélectifs - classe pharmaco-thérapeutique : immunosuppresseurs sélectifs, code atc : l04aa13.leflunomide viatris appartient à un groupe de médicaments appelés médicaments antirhumatismaux. il contient la substance active léflunomide.leflunomide viatris est utilisé chez l’adulte pour le traitement de la polyarthrite rhumatoïde active.les symptômes de la polyarthrite rhumatoïde comprennent inflammation des articulations, gonflement, difficulté à se déplacer et douleur. les autres symptômes qui affectent le corps dans sa globalité comprennent perte d'appétit, fièvre, perte d'énergie et anémie (diminution des globules rouges).
gabapentine viatris 600 mg comp.
viatris gx bv-srl - gabapentine 600 mg - comprimé - 600 mg - gabapentine 600 mg - gabapentin
gabapentine viatris 800 mg comp.
viatris gx bv-srl - gabapentine 800 mg - comprimé - 800 mg - gabapentine 800 mg - gabapentin
rivaroxaban viatris (previously rivaroxaban mylan)
mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - agents antithrombotiques - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers. rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
gabapentine viatris 600 mg comp.
viatris gx bv-srl - gabapentine 600 mg - comprimé - gabapentin
gabapentine viatris 800 mg comp.
viatris gx bv-srl - gabapentine 800 mg - comprimé - gabapentin